Le Lézard
Classified in: Health
Subject: PDT

Lu?mEnvytm Brightening Skin Boosters: The Revolutionary Skincare Elixir Enriched with Salmon DNA Now Available from PDO Max


SYRACUSE, N.Y., June 4, 2024 /PRNewswire/ -- PDO Max proudly announces the U.S. launch of its latest addition to its product line-up, Lu?mEnvytm, an innovative skincare solution enriched with salmon DNA, glutathione, hyaluronic acid, vitamin C, and niacinamide.

Lu?mEnvy is a brightening booster that improves the appearance of skin pigmentation and texture, providing more luminous-looking skin. It is enriched with vitamins and amino acids to restore brightness and promote skin health.

Lu?mEnvy skin serum harnesses the power of polynucleotides derived from salmon DNA, which are renowned for their ability to enhance collagen production and stimulate skin regeneration at the cellular level. This groundbreaking formula hydrates and plumps the skin and offers potent antioxidant properties, making it a comprehensive solution for achieving youthful, glowing skin.

Key Benefits of Lu?mEnvy skin serum:

Skin Rejuvenation: Polydeoxyribonucleotide (PDRN), a key ingredient in this serum, is a polynucleotide which are known to boost collagen synthesis and promote cellular regeneration, improving skin texture and reducing pigmentation.

Hydration & Plumping: Deeply hydrates the skin, enhancing its plumpness and overall appearance.

Antioxidant Protection: Combats free radicals, protecting the skin from environmental damage.

Visible Results: Initial improvements can be seen within 2-4 weeks, with optimal results achieved after three months of consistent use.

"We are incredibly excited to introduce Lu?mEnvy skin serum to the U.S. market," said Giovanna McCarthy, Founder & CEO. "Our dedication to advancing skincare technology is reflected in this product, which combines the best of nature and science. Our proprietary product offers immediate luminosity and long-term rejuvenation, aligning perfectly with our mission to provide innovative and effective skincare solutions."

Our Lu?mEnvy skin booster stands out in the skincare industry for its unique blend of five powerful ingredients:

Salmon DNA (PDRN): Promotes skin regeneration and collagen production.

Glutathione: A master antioxidant that brightens and detoxifies the skin.

Hyaluronic Acid: Provides intense hydration, plumping the skin and enhancing its overall texture.

Vitamin C: Enhances skin brightness and fights oxidative stress.

Niacinamide: Improves skin barrier function and evens out skin tone.

Lu?mEnvy revitalizes the skin, enhancing the results of many aesthetic treatments while helping with the recovery of more intense treatments. For more information about Lu?mEnvy Brightening Skin Boosters or to be among the first to experience its benefits, please visit www.pdomax.com or contact PDO Max at 800-670-0225

For Topical and Cosmetic Use Only. The statements made regarding this product have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease and are not intended for injectable use.

About: PDO MAX, Inc. is headquartered in Liverpool, NY, and is a woman-owned medical device provider for medical aesthetic needs in the U.S. PDO Max is the trusted provider of hundreds of medical practices utilizing its proprietary FDA-cleared (K190245) Polydioxanone (PDO) threads- in-cannula. PDO Max offers hands-on individual instructional courses along with e-Learning courses, which cover the application of PDO thread techniques. For more information regarding PDO MAX, to order our products, or to schedule a training, call us at 800-670-0225 or visit https://www.pdomax.com.

Media Contact:
Diana Daly
800-670-0225
[email protected] 

SOURCE PDO Max, Inc.


These press releases may also interest you

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 19:54
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

at 19:52
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...

at 19:22
Product: Instant Noodle Issue: Food - Allergen - Peanut Distribution: AlbertaBritish ColumbiaOntario See the affected products and product photos for this recall Company information Five Continents International Ltd. Telephone: 416-292-6766| Fax:...

at 18:45
The Samaritan's Purse DC-8 departed our hangar in Greensboro, North Carolina, yesterday morning, with a 13-member Disaster Assistance Response Team (DART) and 24 tons of life-saving relief for hurricane-devastated residents of Grenada in the south...



News published on and distributed by: